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Diabetic mastopathy represents an uncommon tumor-like proliferation of ﬁbrous tissue of the breast
that usually occurs in patients who suffered from type 1 diabetes mellitus for a long time. We report an
uncommon case of diabetic mastopathy presenting in a type 2 non-insulin dependent diabetes mellitus
61-year-old postmenopausal woman. Physical examination revealed a hard, low movable mass in the
upper outer quadrant of the right breast. Mammography and ultrasonography showed typical features of
breast cancer. Ultrasound-guided ﬁne-needle aspiration cytology (US-FNAC) was performed showing
inﬂammatory inﬁltrate, suggesting excisional biopsy. Histological ﬁndings demonstrated typical diabetic
mastopathy with ﬁbrosis, histiocytic and limphocytic inﬁltration without evidence of malignancy.
© 2014 Published by Elsevier Ltd on behalf of Surgical Associates Ltd.1. Introduction
Diabetic mastopathy has been described as a clinicopathologic
entity based on the presence of a benign ﬁbrous disease in breast
tissue in patients affected by type 1 diabetes. Recently few cases of
diabetic mastopathy in type 2 diabetes mellitus patients have been
reported [1e4].
Type 2 diabetes is a serious health problem that affects more
than 7% of adults in developed countries. Up to 16% of patients
affected by breast cancer suffers from diabetes and its two major
risk factors - old age and obesity - are also associated with breast
cancer. Comparative cohort studies and caseecontrol studies sug-
gest that type 2 diabetes may be associated with 10e20% excess
relative risk of breast cancer [5].
Diabetic mastopathy represents less than 1% of benign breast
lesions [2,6e8] presenting with hard, painless, irregularmass of the
breast, clinically and radiologically simulating breast cancer.
Misinterpretation of these masses may result in unnecessary
mastectomies [6,9]. From a histological point of view, diabetic
mastopathy includes lymphocytic ductitis and lobulitis with vary-
ing degrees of keloidal ﬁbrosis, vasculitis, epithelioid ﬁbroblasts,f of Surgical Associates Ltd.and lymphoid nodule formation [2,4,7,10]. We report an uncom-
mon case of diabetic mastopathy in a type II diabetes patient.2. Case report
A 61-year-old woman, who was diagnosed with type 2 diabetes
since 2006 presented to our attention for a palpable mass in the
right breast. She had no microvascular or macrovascular diabetic
complications and she was affected by hypothyroidism (Hashimoto
thyroiditis) in treatment with levothyroxin. Blood sugar was
132 mg/dl while thyroid function tests were all within normal
limits.
Physical examination revealed a hard, low movable mass in the
upper outer quadrant of the right breast. Mammography showed a
localized increased density with architectural distortion and spi-
culated margins, highly suspected for malignancy, in correspon-
dence of the palpable mass (Fig. 1). In addition, it revealed the
presence at the level of the outer quadrants of a further area of
architectural distortionwith similar characteristics, not palpable on
physical examination due to its localization on deep planes.
Dystrophic calciﬁcations have been detected on both breasts,
especially on the right breast, without clinical relevance. The
architectural distortions required further investigations, being
highly suspicious for malignancy.
Fig. 1. Cranio-caudal and medio-lateral oblique mammographic view of the right breast. Two localized, increased density areas with architectural distortion and spiculated margins,
highly suspicious for malignancy at the upper outer quadrant and external quadrant (arrows). Coarse nodular dystrophic calciﬁcations without clinical relevance.
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10x8,2 mm in diameter, with not clearly deﬁned margins and
marked posterior acoustic shadowing (Figs. 2 and 3) in the upper
outer quadrant. The other lesion, on deep planes, on the outer
quadrants showed similar characteristics, measuring 12  11 mm.
Both lesions were suspected for malignancy.
US-FNAC was performed showing mature lymphocytes inter-
mingled with histiocytes.
In February 2014, the two lesions were resected and sent to
histopathologic investigation. An impression of malignancy was
gained from the cut surface of the resected specimen but patho-
logical ﬁndings showed that the lesions consisted of ﬁbrotic breast
stroma with prominent lymphocitic inﬁltrate (Figs. 4 and 5). The
lymphocytes were composed predominantly of B-cells since they
were immunohistochemically positive for CD20. A diagnosis of
diabetic mastopathy was determined.Fig. 2. Ultrasonography of the right breast (external quadrants) revealed a heterogenous hyp
malignancy (12  11 mm).3. Discussion
Diabetic mastopathy is an uncommon tumor-like proliferation
of ﬁbrous tissue of the breast, clinically and radiologically
mimicking breast cancer [11]. Since Soler and Khardori [1] ﬁrst
reported 12 cases of ﬁbrous disease of the breast in associationwith
longstanding type I diabetes mellitus in 1984, 168 cases of diabetic
mastopathy have been reported [12]. Unusually the condition has
also been observed in patients with type II diabetes mellitus and
until 2006, twenty-ﬁve cases of diabetic mastopathy have been
reported [13]. This condition is also found in patients with other
endocrine disorders, especially thyroid diseases [2,7,9]. From 2006
to nowadays other cases have been reported [13,14] but among all
of them, only a few suffered from non-insulin dependent diabetes.
Our patient was affected by type 2 diabetes mellitus and Hashi-
moto’s thyroiditis with hypothyroidism in treatment. Diabeticoechoic area with indistinct margins and posterior acoustical shadowing, suggestive for
Fig. 3. Ultrasonography of the right breast (upper outer quadrant) revealed a heter-
ogenous hypoechoic area with an indistinct margin, posterior acoustical shadowing
and vascular pole on Doppler, suggestive for malignancy (10  8, 2 mm).
Fig. 5. Histology. Fibrotic breast stroma with prominent lymphocitic inﬁltrate; lobular
structures are almost completely absent (haematoxylin and eosin, 10). Note plump
ﬁbroblasts in the stroma (inset, arrow) and the inﬂammatory inﬁltrate with lympho-
cytes and histiocytes (inset, arrow head) (haematoxylin and eosin, 20).
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single or multiple, unilateral or bilateral mass [13]. Seidman et al.
[7] reported a diabetes mean duration of more than 13 years (range
4e27 years) for diabetic mastopathy to develop. In our case, the
patient was affected by diabetes since 2006 (8 years of disease).
Usually, mammographic appearances show the presence of a dense
parenchymal structure with no distortions or microcalciﬁcations
[8,15,16]. In our case, mammography showed an age-related lobular
involution with a focal area of architectural distortion without
microcalciﬁcations. Coarse distrophic calciﬁcations were reported
with no clinical relevance.
Ultrasound ﬁndings vary from irregular hypoechoic mass with
marked acoustic shadowing to a vague hypoechoic area without
shadowing [8,15,16]. In our case, ultrasonography showed malig-
nancy ﬁndings with irregular iso-hypoechoic mass with marked
posterior shadowing.
Magnetic resonance imaging (MRI) ﬁndings vary from no
enhancement to slight heterogeneous enhancement of the mass
[17] and are non-speciﬁc, mimicking those of breast cancer.
Histologic ﬁndings are necessary for the diagnosis of diabetic
mastopathy. Additional data from the literature show that
approximately half of lesions are bilateral or recurrent or both
[4,15]. With reference to recurrence, Camuto et al. [15] reportedFig. 4. Cytology. Stromal fragment in a background with histiocytes and lymphocytes.
No ductal cells are observed (May-Grunwald-Giemsa stain, 10). In the inset, a high
power view of mature lymphocytes intermingled with histiocytes (May-Grunwald-
Giemsa stain, 20).that about 60% of diabetic mastopathy tends to recur after surgical
excision in the same location and involves more breast tissue than
the previous lesion and surgery should not be considered. This
suggests that the natural history of diabetic mastopathy involves a
multicentric ﬁeld effect of diabetes on breast tissue.
Speciﬁc histopathologic characteristics of diabetic mastopathy
include keloidal ﬁbrosis, epithelioid ﬁbroblasts, widespread peri-
vascular/lobular lymphocytic inﬁltration, and widespread peri-
vascular lymphocytic inﬁltration [2]. The frequency of these four
features is approximately 60e70% [4,7] and they are relatively
speciﬁc for insulin-requiring diabetes mellitus. Epithelioid ﬁbro-
blasts are not necessary for the diagnosis of diabetic mastopathy [2]
as they were also seen in patients without a diabetic history [3,4].
Lymphocytic inﬁltration consists predominantly of B-cells, in
contrast with non-diabetic mastitis in which lymphocytic inﬁltra-
tion consists mostly of T-cells [2]. Although the pathogenesis re-
mains still obscure and could be multifactorial, it is generally
believed that these lesions are attributable to extracellular matrix
expansion secondary to increased collagen production and
decreased degradation, in part related to the hyperglycemic state
[2]. Another suspected reason is represented by autoimmune re-
action, ﬁrstly suggested by Soler and Khardori [1] showing lym-
phocytic inﬁltration for B cells [1,2,4,8].4. Conclusions
In conclusion, we should be aware of diabetic mastopathy when
we encounter breast mass in patients with both type 1 and type 2
diabetes mellitus. Because the ﬁndings of diabetic mastopathy by
physical examination, mammography, ultrasonography and MRI
are non-speciﬁc and mimick those of breast cancer [19,20], histo-
logical examination is mandatory. There is no evidence to suggest
that diabetic mastopathy predisposes to the development of breast
carcinoma or stromal neoplastic disease [21] so if typical histo-
logical features of diabetic mastopathy exist at core biopsy, surgery
should be avoided because of the tendency for recurrence.Ethical approval
Ethical approval was not necessary, since the patient in the
study has been treated according to guidelines and no experi-
mental procedures or medications have been used.
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